G. Munozacedo et al., 5-HYDROXYTRYPTAMINE DECREASES SOMATOSTATIN RECEPTORS AND SOMATOSTATIN-RESPONSIVE ADENYLYL-CYCLASE IN RAT PANCREATIC ACINAR MEMBRANES, Life sciences, 60(22), 1997, pp. 1965-1976
Citations number
36
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Pretreatment of pancreatic acini with 5-hydroxytryptamine (5-HT) reduc
ed the binding of the labeled somatostatin (SS) analogue I-125-Tyr(3)-
SMS to pancreatic acinar membranes. This effect was dependent of the d
ose of 5-HT used and length of pretreatment. This inhibitory effect of
5-HT was abolished when pancreatic acini were pretreated with 5-HT in
the presence of the 5-HT1P receptor-antagonist 5-hydroxytryptophyl-5-
hydroxytryptophan amide (5-HTP-DP). Pretreatment of pancreatic acini w
ith 5-HT reduced the inhibition by the stable SS analogue SMS 201-995
of basal and forskolin (FK)-stimulated adenylyl cyclase (AC) activity
in pancreatic acinar membranes. There was no statistical difference es
tablished between IC50 values for the stable GTP analogue 5'-guanylyli
midodiphosphate (Gpp(NH)p) which inhibits Ligand binding to SMS recept
ors in controls and in 5-HT treated pancreatic cells, respectively. In
addition, no significant differences were seen in the level of Gi pro
teins in the control and 5-HT treated pancreatic acini. These data sug
gest that the decrease of the number of I-125-Tyr(3)-SMS receptors, wo
uld explain the decreased sensitivity of AC to SMS 201-995 in membrane
s from 5-HT-pretreated acini.